We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

4 hedge funds and large institutions have $4.11M invested in Entera Bio in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

0.63% more ownership

Funds ownership: 6.1% → 6.72% (+0.63%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

10% less capital invested

Capital invested by funds: $4.57M → $4.11M (-$463K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DAM
DLD Asset Management
New York
+$173K
2
WVP
Worth Venture Partners
New Jersey
+$69.2K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$5.89K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$2.41M – – –
DAM
2
DLD Asset Management
New York
$1.63M +$173K +31,612 +13%
WVP
3
Worth Venture Partners
New Jersey
$73K +$69.2K +12,608 New
UBS Group
4
UBS Group
Switzerland
$2K -$5.89K -1,074 -75%

ENTX Hedge Fund Activity: Q3 2018 in Review

4 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2018, worth a combined $4.11M — down 10% from $4.57M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ENTX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was DLD Asset Management, adding an estimated $173K. The largest seller was UBS Group, cutting an estimated $5.89K.

  • 4 institutional investors held Entera Bio (ENTX) as of Q3 2018, up from 3 in Q2 2018.
  • Funds reported $4.11M of Entera Bio stock for Q3 2018, down 10% quarter-over-quarter.
  • 1 fund opened new Entera Bio positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest Entera Bio buyer in Q3 2018 was DLD Asset Management, an estimated $173K added.
  • The largest Entera Bio seller in Q3 2018 was UBS Group, an estimated $5.89K sold.

Based on aggregated 13F filings for Q3 2018.